explore -WSS

explore

author：explore 2025-09-03 09:24:05 - browse：274

A syringe is prepared at a clinic in Norristown, Pa., Dec. 7, 2021. The Environmental Protection Agency finalized a rule Thursday, March 14, 2024, imposing stricter limits on a chemical used to sterilize medical equipment after finding a higher-than-expected cancer risk at facilities that use ethylene oxide to clean billions of devices including catheters and syringes. ( — The agency first proposed limits on the gas in April 2023, with the goal of reducing emissions by 80%. Now, the agency is predicting an emissions reduction of 90%. Matt Rourke/Ap

On Thursday, the Environmental Protection Agency finalized limits on a carcinogenic gas called ethylene oxide that is used to sterilize most medical devices. Sterilizing facilities had polluted the air unchecked for decades, leading to disproportionately high cancer risks in surrounding communities.

The agency first proposed limits on the gas in April 2023, with the goal of reducing emissions by 80%. Now, the agency is predicting an emissions reduction of 90%. The rule will require commercial sterilization facilities to monitor and submit proof of their reduced emissions. It aligns with the Biden administration’s greater mission to end cancer and commitment to environmental justice, the EPA said.

Ethylene oxide is the most frequently used sterilizing chemical for devices that can’t be exposed to steam. It’s used to sanitize 20 billion devices in the U.S. per year, such as pacemakers, catheters, and ventilators. But long-term exposure to the gas can cause breast cancer, non-Hodgkin’s lymphoma, lymphocytic leukemia, and myeloma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： A revolution in caring for preterm infants

WSS

In 'major milestone,' FDA approves first cell therapy for solid tumors

Peter Marks talks Operation Warp Speed for Rare Diseases

Hospitals are piloting generative AI tools as regulators play catch

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

A new drug could help frostbite victims avoid its ravages

Bernie Sanders bashes nonprofit hospitals over their tax breaks

focus

explore

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

As AI regulations shape up, health tech startups beg for clarity

Jerome Adams on the need for new antivirals for Covid

Weight loss drugs aren’t covered by Obamacare. That may change

Hollywood unions extend contract negotiations for actors

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Hollywood unions extend contract negotiations for actors

Measles policy set amid Florida outbreak alarms vaccine proponents

Novavax promises a turnaround & Lilly roils the obesity market

Humana CEO Bruce Broussard to step down in 2024

focus

Akero's treatment for NASH falls short in cirrhosis study

A fraught question for the kids of Alzheimer’s: Is it coming for us?

In 'major milestone,' FDA approves first cell therapy for solid tumors

Medicare Advantage enrollment hits roughly 33.4 million

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

entertainment

entertainment

hotspot

explore